Ozempic and Birth Control (Oral Contraceptives)
Injectable semaglutide can delay gastric emptying, but evidence suggests it does not meaningfully reduce oral contraceptive bioavailability. In a clinical pharmacokinetic study, once-weekly subcutaneous semaglutide did not reduce exposure to ethinylestradiol/levonorgestrel; levonorgestrel exposure was slightly higher.
Injectable semaglutide can delay gastric emptying, but evidence suggests it does not meaningfully reduce oral contraceptive bioavailability. In a clinical pharmacokinetic study, once-weekly subcutaneous semaglutide did not reduce exposure to ethinylestradiol/levonorgestrel; levonorgestrel exposure was slightly higher.
Key Takeaways
- Available subcutaneous semaglutide evidence does not show reduced oral contraceptive bioavailability.
- Unlike Mounjaro, Ozempic does not carry a specific 4-week oral-contraceptive precaution.
- Backup contraception is not routinely needed for Ozempic alone.
- Backup may be needed if vomiting, severe diarrhea, or missed pills occur during GI illness.
- Semaglutide should not be used during pregnancy; discuss pregnancy planning with a clinician.
Ozempic and Birth Control at a Glance
| Property | Detail |
|---|---|
| Drugs involved | Semaglutide (Ozempic) + oral contraceptives |
| Interaction type | No clinically significant reduction in oral contraceptive bioavailability (study evidence) |
| Overall risk | Low for a direct interaction; moderate if vomiting/diarrhea occurs after pill-taking |
| Specific 4-week warning? | No, that applies to Mounjaro (tirzepatide), not Ozempic |
| Key action | Follow missed-pill / vomiting / diarrhea instructions; consider backup during severe GI illness |
How They Interact
The theoretical concern is that delayed gastric emptying could delay absorption of oral contraceptive hormones. However, a clinical study (Kapitza et al.) found subcutaneous semaglutide did not reduce ethinylestradiol/levonorgestrel bioavailability. Vomiting or severe diarrhea can still reduce absorption independently of any drug interaction.
On the pill and starting Ozempic?
Check semaglutide against your full medication list, including contraceptives. Allmeds clarifies the risks in minutes.
Interaction Profile in Detail
| Dimension | Research summary |
|---|---|
| Mechanism | The theoretical concern is delayed gastric emptying delaying absorption of oral contraceptive hormones. Vomiting or severe diarrhea can also reduce absorption independently of any drug interaction. |
| Clinical evidence | Kapitza et al. found subcutaneous semaglutide did not reduce ethinylestradiol/levonorgestrel bioavailability. |
| Severity | Usually low for a direct semaglutide–oral-contraceptive interaction, but moderate if vomiting/diarrhea occurs after pill-taking. |
| Symptoms to watch | Vomiting soon after contraceptive pill intake, severe diarrhea, missed pills, or pregnancy symptoms. |
| Official guidance | Ozempic labelling states semaglutide delays gastric emptying and may affect oral-medication absorption, but it does not carry the same specific 4-week oral-contraceptive warning as tirzepatide. |
| Practical patient advice | Follow the contraceptive product's missed-pill and vomiting/diarrhea instructions. Consider backup contraception during severe GI illness. |
Symptoms to Watch & When to Seek Care
| Symptom or Sign | What It May Indicate | Action |
|---|---|---|
| Vomiting soon after taking the pill | Possible reduced absorption | Follow the pill's vomiting instructions; consider backup |
| Severe or prolonged diarrhea | Possible reduced absorption | Use backup contraception per product guidance |
| Missed periods, pregnancy symptoms | Possible pregnancy | Take a test; semaglutide is not used in pregnancy |
Common Questions About Ozempic and Birth Control
Available subcutaneous semaglutide evidence does not show reduced oral contraceptive bioavailability.
Not routinely for Ozempic alone, but backup may be needed if vomiting, severe diarrhea, or missed pills occur.
No. Tirzepatide has a specific oral-contraceptive precaution; Ozempic does not carry the same warning.
Follow the contraceptive's instructions for vomiting and consider backup contraception.
No. Semaglutide should not be used during pregnancy, and pregnancy planning should be discussed with a clinician.
Check Ozempic against your full medication list
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile, in minutes.
References
- U.S. Food & Drug Administration. Ozempic (semaglutide) prescribing information. fda.gov.
- U.S. Food & Drug Administration. Wegovy (semaglutide) prescribing information. fda.gov.
- U.S. Food & Drug Administration. Mounjaro (tirzepatide) prescribing information. fda.gov.
- European Medicines Agency. Ozempic / Wegovy / Mounjaro EPAR product information. ema.europa.eu.
- Therapeutic Goods Administration (Australia). Australian Register of Therapeutic Goods (ARTG). tga.gov.au.